Literature DB >> 15972234

Effects of clozapine and 2,5-dimethoxy-4-methylamphetamine [DOM] on 5-HT2A receptor expression in discrete brain areas.

M M Doat-Meyerhoefer1, R Hard, J C Winter, R A Rabin.   

Abstract

Activation of 5-HT2A receptors has been shown to be an essential component of the discriminative stimulus effects of indoleamine and phenethylamine hallucinogens. The objective of the present study was to determine the neuroanatomical location of the 5HT2A receptors which may be responsible for the stimulus effects of the phenethylamine hallucinogen [-]2,5-dimethoxy-4-methylamphetamine (DOM). It was hypothesized that brain areas containing altered 5-HT2A receptor expression in the context of a similar alteration in DOM-induced stimulus control might be important in mediating the stimulus effects of DOM. Fisher 344 rats were treated with either clozapine (25 mg/kg/day) or DOM (2 mg/kg/day) for 7 days, and the consequences of these drug treatment regimens on DOM-induced stimulus control and on 5-HT2A receptor expression in several brain areas were determined. Chronic administration of clozapine was associated with a wide-spread decrease in levels of 5-HT2A/2C receptors. Conversely, treatment with DOM had varied effects including a neuroanatomically selective decrease in 5-HT2A/2C receptor levels that was restricted to the olfactory nucleus. Both chronic treatment with DOM and clozapine decreased the stimulus effects of DOM. The present findings suggest a role for the olfactory nucleus in producing the stimulus effects of DOM.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15972234      PMCID: PMC1351091          DOI: 10.1016/j.pbb.2005.05.011

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  56 in total

1.  Selective visualization of rat brain 5-HT2A receptors by autoradiography with [3H]MDL 100,907.

Authors:  J F López-Giménez; G Mengod; J M Palacios; M T Vilaró
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1997-10       Impact factor: 3.000

Review 2.  Differences between natural and recombinant G protein-coupled receptor systems with varying receptor/G protein stoichiometry.

Authors:  T Kenakin
Journal:  Trends Pharmacol Sci       Date:  1997-12       Impact factor: 14.819

3.  The effects of antipsychotic drugs on the mRNA levels of serotonin 5HT2A and 5HT2C receptors.

Authors:  P R Buckland; U D'Souza; N A Maher; P McGuffin
Journal:  Brain Res Mol Brain Res       Date:  1997-08

4.  Changes in serotonin2A and GABA(A) receptors in schizophrenia: studies on the human dorsolateral prefrontal cortex.

Authors:  B Dean; T Hussain; W Hayes; E Scarr; S Kitsoulis; C Hill; K Opeskin; D L Copolov
Journal:  J Neurochem       Date:  1999-04       Impact factor: 5.372

5.  The effects of clozapine and haloperidol on serotonin-1A, -2A and -2C receptor gene expression and serotonin metabolism in the rat forebrain.

Authors:  P W Burnet; C P Chen; S McGowan; M Franklin; P J Harrison
Journal:  Neuroscience       Date:  1996-07       Impact factor: 3.590

6.  Mechanism of tolerance development to 2,5-dimethoxy-4-iodoamphetamine in rats: down-regulation of the 5-HT2A, but not 5-HT2C, receptor.

Authors:  R L Smith; R J Barrett; E Sanders-Bush
Journal:  Psychopharmacology (Berl)       Date:  1999-06       Impact factor: 4.530

7.  Fluoxetine gradually increases [125I]DOI-labelled 5-HT2A/2C receptors in the hypothalamus without changing the levels of Gq- and G11-proteins.

Authors:  Q Li; N A Muma; G Battaglia; L D Van de Kar
Journal:  Brain Res       Date:  1997-11-14       Impact factor: 3.252

8.  Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action.

Authors:  F X Vollenweider; M F Vollenweider-Scherpenhuyzen; A Bäbler; H Vogel; D Hell
Journal:  Neuroreport       Date:  1998-12-01       Impact factor: 1.837

9.  The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs. I: Antagonist correlation analysis.

Authors:  D Fiorella; R A Rabin; J C Winter
Journal:  Psychopharmacology (Berl)       Date:  1995-10       Impact factor: 4.530

10.  The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs. III: The mechanistic basis for supersensitivity to the LSD stimulus following serotonin depletion.

Authors:  D Fiorella; S Helsley; D S Lorrain; R A Rabin; J C Winter
Journal:  Psychopharmacology (Berl)       Date:  1995-10       Impact factor: 4.530

View more
  5 in total

1.  Neural basis of the potentiated inhibition of repeated haloperidol and clozapine treatment on the phencyclidine-induced hyperlocomotion.

Authors:  Changjiu Zhao; Tao Sun; Ming Li
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2012-03-26       Impact factor: 5.067

2.  Repeated asenapine treatment produces a sensitization effect in two preclinical tests of antipsychotic activity.

Authors:  Rongyin Qin; Yingzhu Chen; Ming Li
Journal:  Neuropharmacology       Date:  2013-08-14       Impact factor: 5.250

3.  Time course of the attenuation effect of repeated antipsychotic treatment on prepulse inhibition disruption induced by repeated phencyclidine treatment.

Authors:  Ming Li; Erik He; Nick Volf
Journal:  Pharmacol Biochem Behav       Date:  2011-03-21       Impact factor: 3.533

4.  Activation of the JAK-STAT pathway is necessary for desensitization of 5-HT2A receptor-stimulated phospholipase C signalling by olanzapine, clozapine and MDL 100907.

Authors:  Rakesh K Singh; Ying Dai; Jeff L Staudinger; Nancy A Muma
Journal:  Int J Neuropsychopharmacol       Date:  2008-10-31       Impact factor: 5.176

5.  Different effects of a single and repeated administration of clozapine on phencyclidine-induced hyperlocomotion and glutamate releases in the rat medial prefrontal cortex at short- and long-term withdrawal from this antipsychotic.

Authors:  Tomohiro Abekawa; Koki Ito; Tsukasa Koyama
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-04-26       Impact factor: 3.195

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.